First Author: O.Ruiz-Moreno SPAIN
Co Author(s): P. Calvo B. Abadia J. Leciñena C. Torrón 0 0 0 0 0 0 0 0 0
Back to previous
To describe a case of a patient who developed multifocal choroiditis (MC) complicated with a choroidal neovascular (CNV) membrane treated with intravitreal ranibizumab.
Case report at Miguel Servet University Hospital, Zaragoza (Spain)
We present a case of a 62-year-old man, previously diagnosed with MC and sudden vision loss in the left eye (OS). A full ophthalmological examination was performed including biomicroscopy, fluorescein angiography (FA) and spectral domain (SD) Cirrus optical coherence tomography (OCT).
Best-corrected visual acuity (BCVA) was 20/200 in the right eye (OD) and 20/60 in the OS. The anterior segment was quiet in both eyes (OU). Intraocular pressure was 18mm Hg OU. Fundoscopy of the OS revealed a subretinal haemorrhage and some yellowish-gray lesions in the macular area. FA showed early hypofluorescence and late hyperfluorescence due to active leakage at the level of the haemorrhage, revealing a CNV membrane due to MC in the OS. SD Cirrus OCT revealed a neurosensory retinal detachment in the OS. Intravitreal injection of ranibizumab was performed in the OS with good response. BCVA improved to 20/20 but 2 months later it recurred. Three additional ranibizumab injections were administered whereby vision stabilized at 20/25. No leakage was observed in FA. The vision remained stable with no flare up for over 12 months
Intravitreal ranibizumab therapy could be a good option for the treatment of CNV in MC that can improve vision and eliminate all inflammatory signs.